Literature DB >> 13489293

The chemotherapy of malignant disease.

R B SCOTT.   

Abstract

Entities:  

Keywords:  CYTOTOXIC DRUGS/therapeutic use; NEOPLASMS/therapy

Mesh:

Substances:

Year:  1958        PMID: 13489293      PMCID: PMC2026603          DOI: 10.1136/bmj.1.5061.1

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  64 in total

1.  Palliation of mammary carcinoma with phosphoramide drugs.

Authors:  J C BATEMAN; H N CARLTON
Journal:  J Am Med Assoc       Date:  1956-10-20

2.  Myleran in treatment of chronic myeloid leukaemia.

Authors:  E K BLACKBURN; G M KING; H T SWAN
Journal:  Br Med J       Date:  1956-04-14

3.  Advanced cancer treated with nitromin.

Authors:  B A STOLL
Journal:  Med J Aust       Date:  1956-12-15       Impact factor: 7.738

4.  Treatment of chronic granulocytic leukemia with myleran.

Authors:  J LOUIS; L R LIMARZI; W R BEST
Journal:  AMA Arch Intern Med       Date:  1956-03

5.  [New clinical studies on the action of actinomycin C].

Authors:  A Ravina; M Pestel
Journal:  Presse Med       Date:  1955-12-03       Impact factor: 1.228

6.  On the heterogeneity of the desoxyribonucleic acids.

Authors:  A BENDICH; P J RUSSELL; G B BROWN
Journal:  J Biol Chem       Date:  1953-07       Impact factor: 5.157

7.  Triethylene melamine in the treatment of neoplastic disease.

Authors:  R W RUNDLES; W B BARTON
Journal:  Blood       Date:  1952-05       Impact factor: 22.113

8.  Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

Authors:  D A KARNOFSKY; J H BURCHENAL; G C ARMISTEAD; C M SOUTHAM; J L BERNSTEIN; L F CRAVER; C P RHOADS
Journal:  AMA Arch Intern Med       Date:  1951-04

9.  The nitrogen mustard-like actions of 2,4,6-tris (ethylenimino)-s-triazine and other bis(ethylenimines).

Authors:  F S PHILIPS; J B THIERSCH
Journal:  J Pharmacol Exp Ther       Date:  1950-12       Impact factor: 4.030

10.  Preliminary studies on the clinical toxicity of 5-amino-7-hydroxy-1-v-triazolo[d]-pyrimidine.

Authors:  G C ARMISTEAD; J H BURCHENAL
Journal:  Cancer       Date:  1949-11       Impact factor: 6.860

View more
  5 in total

1.  Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.

Authors:  A M BARLOW; J T LEEMING; J F WILKINSON
Journal:  Br Med J       Date:  1959-08-22

2.  [Chemotherapy of carcinoma and its experimental principles].

Authors:  H W VASTERLING
Journal:  Arch Gynakol       Date:  1959

3.  Influence of antibiotic therapy on wound inflammation and sepsis associated with orthopaedic implants: a long-term survey.

Authors:  J T Scales; B M Roantree; A G Towers
Journal:  Proc R Soc Med       Date:  1971-06

4.  The environment in childhood and risk of motor neuron disease.

Authors:  C N Martyn; C Osmond
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

5.  Esthiomene resulting from cutaneous tuberculosis of external genitalia.

Authors:  R P Naik; C R Srinivas; C Balachandran; P K Narayan; K Ramnarayan; R C Sahoo
Journal:  Genitourin Med       Date:  1987-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.